Search results
From yawning to stomach cramps - Dr Zoe Williams answers your health questions
The US Sun· 5 days agoDehydration is something many Brits are living with, without even realising it – it might explain...
Novartis Investors to Eye Outlook, Key Drugs at Earnings -- Earnings Preview
Market Watch· 5 days agoNovartis is scheduled to report results for the first quarter on Tuesday. --CORE OPERATING PROFIT: The Swiss pharmaceutical major is set to book $4.245 billion in core operating profit--one ...
UPDATE 4-Novartis raises guidance after beating Q1 expectations
Reuters via Yahoo Finance· 4 days agoSwiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former boss of Bristol Myers Squibb (BMS) to ...
International Assets Investment Management LLC Purchases Shares of 6,572 Lantheus Holdings, Inc....
ETF DAILY NEWS· 1 day agoInternational Assets Investment Management LLC bought a new stake in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the 4th quarter, according to its most recent Form 13F ...
Knights of Columbus Asset Advisors LLC Boosts Stock Position in Lantheus Holdings, Inc....
ETF DAILY NEWS· 6 days agoKnights of Columbus Asset Advisors LLC lifted its position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 125.6% in the fourth quarter, according to the company in its most ...
Lantheus (NASDAQ:LNTH) Price Target Raised to $99.00
ETF DAILY NEWS· 5 days agoThe brokerage currently has a buy rating on the medical equipment provider’s stock. Truist Financial reissued a buy rating and issued a $82.00 target price (up previously from $80.00) on shares ...